Furthermore, a notable correlation was established between NLRP1 downregulation and adverse PFS in ACC, CHOL, and HNSC, while NLRP1 upregulation was associated with detrimental PFS in LGG, PRAD, and STAD (p‐value < 0.05). Here, NLRP1 is linked to prostate adenocarcinoma.